Citation Impact

Citing Papers

Metal nanoparticles: understanding the mechanisms behind antibacterial activity
2017 Standout
VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines
2007 Standout
The HIV vaccine pipeline, from preclinical to phase III
2001
Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents
2005 Standout
The basis for HIV immunotherapeutic vaccines
2001
Current progress in the development of human immunodeficiency virus vaccines: research and clinical trials
2001
Nonhuman Primates: A Critical Role in Current Disease Research
2001
Tolerance, Danger, and the Extended Family
1994 Standout
Angiogenesis in health and disease
2003 Standout
Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model
2005
Recent progress in the development of coumarin derivatives as potent anti‐HIV agents
2003 Standout
Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia
2000 Nature
The role of sexually transmitted diseases in HIV transmission
2004 Standout
Inhibition of Tat-mediated Transactivation and HIV-1 Replication by Human Anti-hCyclinT1 Intrabodies
2003
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Reverse vaccinology, a genome-based approach to vaccine development
2001
Gene therapy for HIV infection: what does it need to make it work?
2006 StandoutNobel
Stable Cytotoxic T Cell Escape Mutation in Hepatitis C Virus Is Linked to Maintenance of Viral Fitness
2008 StandoutNobel
New prospects for the development of a vaccine against human immunodeficiency virus type 1. An overview
1999
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
2008 Standout
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
2006 Standout
Repression of MHC determinants in HIV infection
2001
The roles of nonhuman primates in the preclinical evaluation of candidate AIDS vaccines
2004
Preparation of Clinical‐Grade Recombinant Canarypox–Human Immunodeficiency Virus Vaccine–Loaded Human Dendritic Cells
2002 StandoutNobel
Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus
2006 StandoutNobel
Vaccines for the prevention of HIV-1 disease
2001
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Cell Selection by Antigen in the Immune Response
1969 StandoutNobel
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Vaccine Protection against Simian Immunodeficiency Virus by Recombinant Strains of Herpes Simplex Virus
2000
Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+T cell hyperactivation and HIV type 1 replication
2000
Nanoparticles in modern medicine: state of the art and future challenges.
2007
Activation of Natural Killer T Cells by α-Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein
2003 StandoutNobel
International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors
2000 Standout
Angiogenic Effects of Extracellular Human Immunodeficiency Virus Type 1 Tat Protein and Its Role in the Pathogenesis of AIDS-Associated Kaposi's Sarcoma
2002
Atraumatic Oral Spray Immunization with Replication-Deficient Viral Vector Vaccines
2007 StandoutNobel
The Regulatory Influence of Activated T Cells on B Cell Responses to Antigen
1972 StandoutNobel
Long oligonucleotide microarrays for African green monkey gene expression profile analysis
2007 StandoutNobel
HIV Gag mRNA Transfection of Dendritic Cells (DC) Delivers Encoded Antigen to MHC Class I and II Molecules, Causes DC Maturation, and Induces a Potent Human In Vitro Primary Immune Response
2000 StandoutNobel
The Mechanism of Immunological Paralysis
1968
Cell interactions in the induction of tolerance: the role of thymic lymphocytes.
1970 Standout
Tat as one key to HIV-induced immune pathogenesis and Pat toxoid as an important component of a vaccine
1999

Works of Monica Pace being referenced

SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccine
2000
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine
1999
THE ELIMINATION OF MOUSE AND BOVINE GLOBULINS FROM THE CIRCULATION OF NEWBORN AND ADULT MICE
1961
Rankless by CCL
2026